Skip to content

Amprius Technologies AMPX Impairment charges for facilities consolidation

Impairment charges for facilities consolidation at other companies

Valero Energy logo
Valero EnergyVLO
$0-100%
Meta Platforms, Inc. logo
Meta Platforms, Inc.META
$0-100%
Monster Beverage logo
Monster BeverageMNST
$0-100%
LXP Industrial Trust logo
LXP Industrial TrustLXP
$0
Ingredion logo
IngredionINGR
$2.5M-90.8%
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
$12.18M

Other financials

Income statement

See full
Revenue$28.5M+153%
Gross profit$5.7M+343%
Operating income-$6.7M+30.9%
Net income-$5.0M+46.2%
EPS (diluted)-$0.04+50.0%

Balance sheet

See full
Cash & equivalents$62.6M+25.5%
Total debt$6.6M-82.6%
Total equity$109.4M+55.4%
Total assets$130.8M+10.4%

Cash flow

See full
Operating cash flow-$37.3M-164%
CapEx$980.0K+7.3%
Free cash flow-$38.3M-154%

Valuation

See full
Market cap$1.77B+631%

Profitability

See full
Gross margin18.1%+10.5pp
Operating margin-48.4%-19.0pp
Net margin-44%-17.6pp
FCF margin-65.1%-19.6pp

Returns & leverage

See full
Return on equity-44.2%-11.4pp
Debt / equity0.1×-0.5×
Current ratio7.1×+2.4×

Where this comes from

Reported directly by Amprius Technologies in its filing.

Tagged under the XBRL concept us-gaap:ImpairmentOfLongLivedAssetsHeldForUse.

The official record: Amprius Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amprius Technologies's impairment charges for facilities consolidation.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amprius Technologies's impairment charges for facilities consolidation?
Amprius Technologies (AMPX) reported impairment charges for facilities consolidation of $77K in Q1 2026.